Use of Lactobacillus to prevent infection by pathogenic bacteria

Microbes and Infection

Volumn 4, Issue 3, 2002, Pages 319-324

  Reid, Gregor ^a   Burton, Jeremy ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Disease management; Lactobacilli; Probiotics; Urogenital and gastrointestinal pathogens

Indexed keywords

BACTERIOCIN; HYDROGEN PEROXIDE; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CANDIDA; CLOSTRIDIUM DIFFICILE; ESCHERICHIA COLI O157; FLORA; GASTROENTERITIS; GROWTH INHIBITION; HUMAN; IMMUNOMODULATION; INFECTION PREVENTION; INGESTION; INTESTINE INFECTION; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SALMONELLA; SIGNAL TRANSDUCTION; UROGENITAL TRACT INFECTION; VAGINITIS;

BACTERIAL INFECTIONS; HUMANS; INTESTINAL DISEASES; LACTOBACILLUS; PROBIOTICS; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; ROTAVIRUS;

EID: 0036218741     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01544-7     Document Type: Review

References (71)

1. Examination of strains of lactobacilli for properties which may influence bacterial interference in the urinary tract
2. Probiotic immunomodulation in health and disease
3. Normal flora: Diversity and functions
4. Detection of a Lactobacillus substance which inhibits Escherichia coli
5. Interference in initial adhesion of uropathogenic bacteria and yeasts silicone rubber by a Lactobacillus acidophilus biosurfactant
6. Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora
7. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections
8. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections
9. Haemagglutination and glycolipid-binding activities of Lactobacillus reuteri
10. Virulence factors in Escherichia coli urinary tract infection
11. The role of iron in infection
12. From the cover: Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses
13. Colonization of the urinary tract with live bacteria from the normal fecal and urethral flora in patients with recurrent symptomatic urinary tract infections
14. Immunomodulation by treatment with Lactobacillus casei strain Shirota
15. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial
16. Pathogenic diversity of Escherichia coli and the emergence of 'exotic' islands in the gene stream
17. P fimbriae and aerobactin as intestinal colonization factors for Escherichia coli in Pakistani infants
18. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function
19. Oral probiotics can resolve urogenital infections
20. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients
21. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections
22. Effect on the urogenital flora of antibiotic therapy for urinary tract infection
23. Nutrient uptake by Candida albicans: The influence of cell surface mannoproteins
24. Differences in the acid-labile component of Candida albicans mannan from hydrophobic and hydrophilic yeast
25. Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans
26. A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix
27. The expression of the pathogenic yeast Candida albicans catalase gene in response to hydrogen peroxide
28. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
29. 2-generating lactobacilli
30. Lactobacillus GG vaginal suppositories and vaginitis
31. Lactobacillus acidophilus and yogurt in the prevention and therapy of bacterial vaginosis
32. The range of antagonistic effects of Lactobacillus bacterial strains on etiologic agents of bacterial vaginosis
33. Pore-forming and haemolytic properties of the Gardnerella vaginalis cytolysin
34. Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis
35. Bacterial vaginosis: A public health review
36. Hydrogen peroxide production by Lactobacillus species, correlation with susceptibility to the spermicidal compound nonoxynol- 9
37. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification
38. Lactobacilli and vaginal host defense: Activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB
39. Bacterial vaginosis, a public health problem for women
40. Do vaginal lactobacilli prevent preterm labour?
41. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: A randomized, controlled trial
42. Bacterial vaginosis: A threat to reproductive health? Historical perspectives, current knowledge, controversies and research demands
43. Treatment of bacterial vaginosis with lactobacilli
44. Therapy of bacterial vaginosis using exogenously applied Lactobacillus acidophilus and a low dose of estriol: A placebo-controlled multicentre clinical trial
45. Vaccination against nonspecific bacterial vaginosis. Double-blind study of Gynatren
46. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions
47. Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: Evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules
48. Enteropathogenic Escherichia coli (EPEC) attachment to epithelial cells: Exploiting the host cell cytoskeleton from the outside
49. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-poducing Escherichia coli O157:H7 infection in infant rabbits
50. Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria
51. Inhibition of bacterial pathogens by lactobacilli
52. Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals
53. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells
54. Effects of Clostridium difficile toxins on epithelial cell barrier
55. SifA permits survival and replication of Salmonella typhimurium in murine macrophages
56. Interactions mediating bacterial translocation in the immature intestine
57. Probiotics in the treatment of diarrheal diseases
58. Rotavirus vaccines: Current controversies and future directions
59. A viral enterotoxin. A new mechanism of virus-induced pathogenesis
60. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection
61. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
62. Probiotics in pediatric gastrointestinal disorders
63. Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomized trial
64. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants
65. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
66. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial
67. The underuse of probiotics by family physicians
68. Developmental microbial ecology of the neonatal gastrointestinal tract
69. Probiotics and inflammatory bowel disease: Is there a scientific rationale?
70. Probiotics: Future directions
71. Probiotic agents to protect the urogenital tract against infection